Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Anticipated Size Of The Polygenic Risk Score Services Market Over The Five-Year Period 2025–2029?
The polygenic risk score services market size has expanded considerably in recent years. This market is expected to surge from $1.24 billion in 2024 to $1.45 billion in 2025, achieving a compound annual growth rate (CAGR) of 16.9%. The past growth witnessed in this market stems from factors such as the increasing prevalence of chronic diseases, the escalating demand for personalized medicine, a heightened awareness of genetic predispositions, the growing availability of direct-to-consumer genetic testing, and the increasing adoption of genomic research in healthcare.
The polygenic risk score services market is set for rapid expansion over the next few years, with projections indicating it will reach $2.68 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 16.5%. This growth during the forecast period is primarily driven by the increasing integration of artificial intelligence in genomics, a rising demand for preventive healthcare solutions, growing investments in genomic research and development, the expanding integration of electronic health records with genetic data, and the increasing availability of polygenic risk score-based testing services. Noteworthy trends expected in this period include technological advancements in polygenic risk score algorithms, innovations in multi-omics data integration, developments in ancestry-informed polygenic risk scoring, extensive research and development into gene-environment interactions, and progress in pharmacogenomics applications.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28302&type=smp
What Are The Emerging Market Drivers Creating New Opportunities In The Polygenic Risk Score Services Industry?
The increasing focus on personalized medicine is anticipated to fuel the expansion of the polygenic risk score services market in the future. This healthcare method involves customizing prevention, diagnosis, and treatment based on a person’s unique genetic makeup, environmental influences, and lifestyle choices. The rise of personalized medicine stems from advancements in genomics, which provide greater insight into individual genetic differences, leading to more accurate and focused treatments that enhance patient results and minimize ineffective therapeutic trials. Polygenic risk score (PRS) services support personalized medicine by assessing numerous genetic variations to gauge a person’s likelihood of developing particular diseases, thereby allowing healthcare professionals to formulate customized prevention tactics, prompt interventions, and bespoke treatment regimens aligned with each patient’s genetic profile. As an illustration, in February 2024, the US-based non-profit organization, Personalized Medicine Coalition, reported that the FDA approved 16 novel personalized treatments for rare disease patients in 2023, an increase from six in 2022. Among the personalized treatments newly sanctioned in 2023 were also seven cancer drugs and three for other diseases and conditions. Consequently, the increased focus on personalized medicine is fostering the expansion of the polygenic risk score services market.
Which Key Segments Fueling The Polygenic Risk Score Services Market?
The polygenic risk score services market covered in this report is segmented as
1) By Service Type: Genotyping, Sequencing, Data Analysis, Reporting, Other Service Types
2) By Application: Disease Risk Assessment, Personalized Medicine, Research, Other Applications
3) By End-User: Hospitals And Clinics, Research Institutes, Direct-to-Consumer, Other End-Users
Subsegments:
1) By Genotyping: Array-Based Genotyping, Targeted Genotyping, High-Throughput Genotyping
2) By Sequencing: Whole Genome Sequencing (Wgs), Whole Exome Sequencing (Wes), Targeted Sequencing
3) By Data Analysis: Polygenic Risk Prediction Algorithms, Bioinformatics And Statistical Analysis, Data Integration With Electronic Health Records (Ehr)
4) By Reporting: Clinical Reports For Healthcare Providers, Direct-To-Consumer (Dtc) Reports, Risk Stratification Reports (Disease-Specific)
5) By Other Service Types: Genetic Counseling Services, Data Storage And Cloud-Based Platforms, Prs Software And Toolkits
Which Market Trends Are Creating New Opportunities In The Polygenic Risk Score Services Industry?
Major companies within the polygenic risk score services market are concentrating on developing innovative solutions such as pharmacogenomics to elevate personalized treatment strategies and improve patient outcomes. Pharmacogenomics involves the study of how an individual’s genetic makeup influences their response to drugs, thereby enabling more precise and tailored treatment. For instance, in July 2025, Bupa, a UK-based health insurance company, launched a new suite of DNA-based tests aimed at supporting personalized health and wellness insights. This suite provides personalized information on medication response and disease risk, allowing for earlier detection and customized treatment for conditions such as cancer, diabetes, and heart disease. These tests contribute to preventing side effects, enhancing long-term health outcomes, and empowering individuals to take proactive steps for themselves and their families. The overall purpose is to transition healthcare from a reactive treatment model to preventive, precision health management.
Which Key Market Players Are Investing In Expansion And Innovation Of Polygenic Risk Score Services Market?
Major companies operating in the polygenic risk score services market are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Illumina Inc., Endeavor Health Inc., Myriad Genetics Inc., The Broad Institute of MIT and Harvard, BGI Group, Invitae Corporation, 23andMe Holding Co., Color Health Inc., Genomics Ltd., Cogentech S.R.L., Gene by Gene Ltd., Our Future Health Ltd., Mapmygenome India Limited, Australian Genome Research Facility (AGRF) Ltd., Golden Helix Inc., Allelica Inc., Antegenes OÜ, GeninCode Plc.
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/polygenic-risk-score-services-global-market-report
Which Region Is Projected To Lead The Polygenic Risk Score Services Market During The Forecast Period?
North America was the largest region in the polygenic risk score services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in polygenic risk score (PRS) services report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Request A Customized Version Of The Polygenic Risk Score Services Market Report:
https://www.thebusinessresearchcompany.com/customise?id=28302&type=smp
Browse Through More Reports Similar to the Global Polygenic Risk Score Services Market 2025, By The Business Research Company
Dna Repair Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/dna-repair-drugs-global-market-report
Soft Tissue Repair Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/soft-tissue-repair-global-market-report
Oligonucleotides Therapy Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/oligonucleotides-therapy-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model